Hoppner, Jorge http://orcid.org/0000-0003-2157-9333
van Genabith, Levin
Hielscher, Thomas
Heger, Ulrike
Sperling, Lucas
Colbatzky, Teresa
Gutjahr, Ewgenija
Lang, Matthias
Pausch, Thomas
Spektor, Anna-Maria
Glatting, Frederik M.
Liermann, Jakob
Hackert, Thilo
Kratochwil, Clemens
Giesel, Frederik L.
Haberkorn, Uwe
Röhrich, Manuel http://orcid.org/0000-0001-7609-243X
Funding for this research was provided by:
Federal Ministry of Education and Research (13N 13341)
Universitätsklinikum Heidelberg
Article History
Received: 9 May 2023
Accepted: 18 September 2023
First Online: 19 October 2023
Competing interests
: UH, CK and FLG have filed a patent application for quinoline-based FAP targeting agents for imaging and therapy in nuclear medicine. UH, CK and FLG also has shares of a consultancy group for iTheranostics. No other potential conflicts of interest relevant to this article exist.